why choose us

First received: April 10, 2023

Clinical Trial: Cannabidiol to Reduce Anxiety Reactivity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Social Anxiety

Study Type: INTERVENTIONAL


Official Title: Endocannabinoid System Engagement to Reduce Anxiety Reactivity With Cannabidiol in Social Anxiety Disorder (R61 Project)

Brief Summary: This study seeks to understand how cannabidiol (CBD) - a non-intoxicating chemical compound obtained from the Cannabis sativa plant - affects biological and stress-related responses that are believed to underlie anxiety disorders.This study will evaluate the effects of different doses of CBD on blood plasma levels of anandamide (a molecule in the brain that has been shown to help regulate stress responses; primary biological signature) and anxiety reactivity to a standardized stress task (secondary target) in an…

Read more